The role of modern antithrombotic agents in cardiovascular disease prevention
Atherosclerosis is one of the most urgent problems in modern cardiology. Atherosclerosis instability and coronary heart disease clinical course are based on plaque ulceration, rupture, and atherothrombosis. Atherothrombosis causes 28% of all deaths worldwide. Therefore, usage of medications targeted...
Main Authors: | O. M. Drapkina, A. V. Klimenkov, V. T. Ivashkin |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
1970-01-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1677 |
Similar Items
-
THE ROLE OF MODERN ANTIPLATELET THERAPY IN PREVENTION OF ATHEROTHROMBOSIS: THE IMPORTANCE OF CLOPIDOGREL AND ITS GENERIC DRUGS
by: O. V. Gaisenok
Published: (2016-01-01) -
INFLUENCE OF SWITCHING OF CLOPIDOGREL TO TICAGRELOR ON THE DEVELOPMENT OF CARDIOVASCULAR EVENTS IN PATIENTS WITH ST SEGMENT ELEVATION
by: E. V. Tavlueva, et al.
Published: (2017-11-01) -
MECHANISMS OF CARDIOVASCULAR DISEASES DEVELOPMENT IN OBESITY AND INSULIN RESISTANCE: FOCUS ON ATHEROTHROMBOSIS
by: V. N. Shishkova
Published: (2016-09-01) -
THE MODERN ASPECTS OF CLOPIDOGREL USE
by: E. N. Dankovtseva, et al.
Published: (2016-01-01) -
ANTITHROMBOTIC THERAPY OF ISCHEMIC HEART DISEASE: FROM FAST ACTING ANTIAGGREGANTS TO STATINES AND NITRATE OXIDE. IS IT REAL?
by: I. A. Latfullin, et al.
Published: (2016-01-01)